{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:26:58Z","timestamp":1784032018622,"version":"3.55.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["R01TS000324-01-00"],"award-info":[{"award-number":["R01TS000324-01-00"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["MegaALS 802091"],"award-info":[{"award-number":["MegaALS 802091"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2023-02428"],"award-info":[{"award-number":["2023-02428"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["MegaALS 802091"],"award-info":[{"award-number":["MegaALS 802091"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.lanepe.2024.101173","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T16:27:42Z","timestamp":1733848062000},"page":"101173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Association between cardiometabolic diseases and the risk and progression of motor neuron diseases in Sweden: a population-based case\u2013control study"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4733-5698","authenticated-orcid":false,"given":"Charilaos","family":"Chourpiliadis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6397-5011","authenticated-orcid":false,"given":"Anik\u00f3","family":"Lovik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8948-4376","authenticated-orcid":false,"given":"Yihan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6033-3734","authenticated-orcid":false,"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petter","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayomand","family":"Press","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Samuelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Ingre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7628","key":"10.1016\/j.lanepe.2024.101173_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: from genes to mechanism","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.lanepe.2024.101173_bib2","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.lanepe.2024.101173_bib3","doi-asserted-by":"crossref","DOI":"10.1177\/17539447231177175","article-title":"Lifestyle or pharmacotherapy in cardio-metabolic disease prevention","volume":"17","author":"Seidu","year":"2023","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.lanepe.2024.101173_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jocn.2021.12.021","article-title":"Cardiovascular comorbidities in amyotrophic lateral sclerosis: a systematic review","volume":"96","author":"Xu","year":"2022","journal-title":"J\u00a0Clin Neurosci"},{"issue":"8","key":"10.1016\/j.lanepe.2024.101173_bib5","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/jamaneurol.2015.0910","article-title":"Diabetes mellitus, obesity, and diagnosis of amyotrophic lateral sclerosis: a population-based study","volume":"72","author":"Kioumourtzoglou","year":"2015","journal-title":"JAMA Neurol"},{"issue":"11","key":"10.1016\/j.lanepe.2024.101173_bib6","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/ene.12632","article-title":"Association between diabetes and amyotrophic lateral sclerosis in Sweden","volume":"22","author":"Mariosa","year":"2015","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101173_bib7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/ene.13465","article-title":"The role of pre-morbid diabetes on developing amyotrophic lateral sclerosis","volume":"25","author":"D'Ovidio","year":"2018","journal-title":"Eur J Neurol"},{"issue":"9","key":"10.1016\/j.lanepe.2024.101173_bib8","first-page":"2233","article-title":"Type II diabetes mellitus and the incidence of amyotrophic lateral sclerosis","volume":"266","author":"Tsai","year":"2019","journal-title":"J\u00a0Neurol"},{"issue":"20","key":"10.1016\/j.lanepe.2024.101173_bib9","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1212\/WNL.0b013e3181c1df1e","article-title":"Lower serum lipid levels are related to respiratory impairment in patients with ALS","volume":"73","author":"Chio","year":"2009","journal-title":"Neurology"},{"issue":"7-8","key":"10.1016\/j.lanepe.2024.101173_bib10","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1080\/21678421.2018.1511731","article-title":"Relationship of statins and other cholesterol-lowering medications and risk of amyotrophic lateral sclerosis in the US elderly","volume":"19","author":"Freedman","year":"2018","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"10","key":"10.1016\/j.lanepe.2024.101173_bib11","first-page":"1949","article-title":"Prior medical conditions and the risk of amyotrophic lateral sclerosis","volume":"261","author":"Seelen","year":"2014","journal-title":"J\u00a0Neurol"},{"issue":"6","key":"10.1016\/j.lanepe.2024.101173_bib12","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/jnnp.2010.236752","article-title":"Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis","volume":"82","author":"Sutedja","year":"2011","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"13","key":"10.1016\/j.lanepe.2024.101173_bib13","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1212\/01.wnl.0000285080.70324.27","article-title":"Dyslipidemia is a protective factor in amyotrophic lateral sclerosis","volume":"70","author":"Dupuis","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.lanepe.2024.101173_bib14","doi-asserted-by":"crossref","first-page":"202.e1","DOI":"10.1016\/j.neurobiolaging.2018.03.022","article-title":"Polygenic link between blood lipids and amyotrophic lateral sclerosis","volume":"67","author":"Chen","year":"2018","journal-title":"Neurobiol Aging"},{"issue":"7","key":"10.1016\/j.lanepe.2024.101173_bib15","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/ene.15810","article-title":"Lipids and amyotrophic lateral sclerosis: a two-sample Mendelian randomization study","volume":"30","author":"Xia","year":"2023","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.lanepe.2024.101173_bib16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/jnnp-2011-301161","article-title":"Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study","volume":"83","author":"Turner","year":"2012","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"issue":"6","key":"10.1016\/j.lanepe.2024.101173_bib17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000526982","article-title":"Cardiovascular diseases, medications, and ALS: a population-based case-control study","volume":"56","author":"Abdel Magid","year":"2022","journal-title":"Neuroepidemiology"},{"issue":"7-8","key":"10.1016\/j.lanepe.2024.101173_bib18","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1080\/21678421.2016.1208247","article-title":"Cardiovascular disease and diagnosis of amyotrophic lateral sclerosis: a population based study","volume":"17","author":"Kioumourtzoglou","year":"2016","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"5-6","key":"10.1016\/j.lanepe.2024.101173_bib19","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3109\/17482960802320545","article-title":"Factors associated with survival in the national registry of veterans with ALS","volume":"10","author":"Pastula","year":"2009","journal-title":"Amyotroph Lateral Scler"},{"issue":"4","key":"10.1016\/j.lanepe.2024.101173_bib20","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/ene.12015","article-title":"Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis","volume":"20","author":"K\u00f6rner","year":"2013","journal-title":"Eur J Neurol"},{"issue":"7-8","key":"10.1016\/j.lanepe.2024.101173_bib21","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1080\/21678421.2017.1336560","article-title":"Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study","volume":"18","author":"Moglia","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"8","key":"10.1016\/j.lanepe.2024.101173_bib22","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/ene.14300","article-title":"Statins, diabetes mellitus and prognosis of amyotrophic lateral sclerosis: data from 501 patients of a population-based registry in southwest Germany","volume":"27","author":"Schumacher","year":"2020","journal-title":"Eur J Neurol"},{"issue":"7-8","key":"10.1016\/j.lanepe.2024.101173_bib23","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3109\/21678421.2015.1062517","article-title":"Effect of lipid profile on prognosis in the patients with amyotrophic lateral sclerosis: insights from the olesoxime clinical trial","volume":"16","author":"Rafiq","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101173_bib24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/mus.22114","article-title":"Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis","volume":"44","author":"Paganoni","year":"2011","journal-title":"Muscle Nerve"},{"issue":"17","key":"10.1016\/j.lanepe.2024.101173_bib25","doi-asserted-by":"crossref","first-page":"e1835","DOI":"10.1212\/WNL.0000000000009322","article-title":"Lipids, apolipoproteins, and prognosis of amyotrophic lateral sclerosis","volume":"94","author":"Ingre","year":"2020","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.lanepe.2024.101173_bib26","first-page":"3082","article-title":"Association of blood lipids with onset and prognosis of amyotrophic lateral sclerosis: results from the ALS Swabia registry","volume":"270","author":"Michels","year":"2023","journal-title":"J\u00a0Neurol"},{"issue":"7-8","key":"10.1016\/j.lanepe.2024.101173_bib27","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1080\/21678421.2018.1497065","article-title":"The Swedish motor neuron disease quality registry","volume":"19","author":"Longinetti","year":"2018","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"5","key":"10.1016\/j.lanepe.2024.101173_bib28","first-page":"293","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler"},{"issue":"9","key":"10.1016\/j.lanepe.2024.101173_bib29","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/aje\/kwn217","article-title":"What do case-control studies estimate? Survey of methods and assumptions in published case-control research","volume":"168","author":"Knol","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"11","key":"10.1016\/j.lanepe.2024.101173_bib30","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/0021-9681(76)90073-4","article-title":"How many controls?","volume":"29","author":"Gail","year":"1976","journal-title":"J\u00a0Chron Dis"},{"issue":"2","key":"10.1016\/j.lanepe.2024.101173_bib31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/oxfordjournals.aje.a009786","article-title":"Factors influencing the optimal control-to-case ratio in matched case-control studies","volume":"149","author":"Hennessy","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.lanepe.2024.101173_bib32","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"issue":"1-2","key":"10.1016\/j.lanepe.2024.101173_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","article-title":"The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III)","volume":"169","author":"Cedarbaum","year":"1999","journal-title":"J\u00a0Neurol Sci"},{"issue":"6","key":"10.1016\/j.lanepe.2024.101173_bib34","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/ene.14190","article-title":"Antidiabetics, statins and the risk of amyotrophic lateral sclerosis","volume":"27","author":"Mariosa","year":"2020","journal-title":"Eur J Neurol"},{"issue":"5","key":"10.1016\/j.lanepe.2024.101173_bib35","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/ana.24936","article-title":"Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: a more than 20-year follow-up of the Swedish AMORIS cohort","volume":"81","author":"Mariosa","year":"2017","journal-title":"Ann Neurol"},{"issue":"14","key":"10.1016\/j.lanepe.2024.101173_bib36","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1212\/WNL.0b013e3182a6cc13","article-title":"Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study","volume":"81","author":"Turner","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101173_bib37","article-title":"Chronic low-grade inflammation associated with higher risk and earlier onset of cardiometabolic multimorbidity in middle-aged and older adults: a population-based cohort study","volume":"14","author":"Cheng","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101173_bib38","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1038\/s41467-022-34526-9","article-title":"T\u00a0cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression","volume":"13","author":"Yazdani","year":"2022","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.lanepe.2024.101173_bib39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","article-title":"Microglia in neurodegenerative disease","volume":"6","author":"Perry","year":"2010","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1016\/j.lanepe.2024.101173_bib40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nri2015","article-title":"Systemic infections and inflammation affect chronic neurodegeneration","volume":"7","author":"Perry","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.lanepe.2024.101173_bib41","first-page":"14doi","article-title":"Circulating levels of cytokines and risk of cardiovascular disease: a Mendelian randomization study. Original Research","author":"Wei","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.lanepe.2024.101173_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2017.00242","article-title":"The dual role of microglia in ALS: mechanisms and therapeutic approaches. Mini review","volume":"9","author":"Geloso","year":"2017","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"10.1016\/j.lanepe.2024.101173_bib43","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/nan.12502","article-title":"Pro-inflammatory activation of microglia in the brain of patients with sepsis","volume":"45","author":"Zrzavy","year":"2019","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"12","key":"10.1016\/j.lanepe.2024.101173_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0355-7","article-title":"Mitochondrial dysfunction and oxidative stress in heart disease","volume":"51","author":"Peoples","year":"2019","journal-title":"Exp Mol Med"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101173_bib45","article-title":"The role of oxidative stress in cardiac disease: from physiological response to injury factor","volume":"2020","author":"D'Oria","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.lanepe.2024.101173_bib46","first-page":"9doi","article-title":"Oxidative stress and mitochondrial damage: importance in non-SOD1 ALS. Mini Review","author":"Carr\u00ec","year":"2015","journal-title":"Front Cell Neurosci"},{"issue":"9","key":"10.1016\/j.lanepe.2024.101173_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094958","article-title":"The contribution of small vessel disease to neurodegeneration: focus on alzheimer's disease, Parkinson's disease and multiple sclerosis","volume":"22","author":"Paolini Paoletti","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101173_bib48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/HYPERTENSIONAHA.123.19943","article-title":"Cerebral small vessel disease, hypertension, and vascular contributions to cognitive impairment and dementia","volume":"81","author":"Hainsworth","year":"2024","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.lanepe.2024.101173_bib49","first-page":"2130","article-title":"Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group","volume":"267","author":"Diekmann","year":"2020","journal-title":"J\u00a0Neurol"},{"issue":"2","key":"10.1016\/j.lanepe.2024.101173_bib50","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000398","article-title":"ALS in Danish Registries: heritability and links to psychiatric and cardiovascular disorders","volume":"6","author":"Trabjerg","year":"2020","journal-title":"Neurol Genet"},{"issue":"4","key":"10.1016\/j.lanepe.2024.101173_bib51","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/ene.12015","article-title":"Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis","volume":"20","author":"K\u00f6rner","year":"2013","journal-title":"Eur J Neurol"},{"issue":"6","key":"10.1016\/j.lanepe.2024.101173_bib52","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/ene.13620","article-title":"Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis","volume":"25","author":"Mandrioli","year":"2018","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101173_bib53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/ene.15584","article-title":"Mutation-specific metabolic profiles in presymptomatic amyotrophic lateral sclerosis","volume":"30","author":"Xia","year":"2023","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.lanepe.2024.101173_bib54","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3389\/fneur.2019.01205","article-title":"Metabolic alteration and amyotrophic lateral sclerosis outcome: a systematic review","volume":"10","author":"Brito","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.lanepe.2024.101173_bib55","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3389\/fneur.2017.00479","article-title":"Cardiac findings in amyotrophic lateral sclerosis: a magnetic resonance imaging study","volume":"8","author":"Rosenbohm","year":"2017","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.lanepe.2024.101173_bib56","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3109\/17482960903390855","article-title":"Impairment of cardiac autonomic control in patients with amyotrophic lateral sclerosis","volume":"11","author":"Pavlovic","year":"2010","journal-title":"Amyotroph Lateral Scler"},{"issue":"5","key":"10.1016\/j.lanepe.2024.101173_bib57","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/01.wco.0000183114.76056.0e","article-title":"Autonomic impairment in amyotrophic lateral sclerosis","volume":"18","author":"Baltadzhieva","year":"2005","journal-title":"Curr Opin Neurol"},{"issue":"1-2","key":"10.1016\/j.lanepe.2024.101173_bib58","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jns.2007.01.007","article-title":"Sympathetic disturbances increase risk of sudden cardiac arrest in sporadic ALS","volume":"254","author":"Asai","year":"2007","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.lanepe.2024.101173_bib59","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1752-1947-8-224","article-title":"Autonomic etiology of heart block in amyotrophic lateral sclerosis: a case report","volume":"8","author":"Shemisa","year":"2014","journal-title":"J\u00a0Med Case Rep"},{"key":"10.1016\/j.lanepe.2024.101173_bib60","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ijcard.2015.10.176","article-title":"Sudden cardiac death in neuromuscular disorders","volume":"203","author":"Finsterer","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.lanepe.2024.101173_bib61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.trsl.2017.02.004","article-title":"Smoking and the risk of type 2 diabetes","volume":"184","author":"Maddatu","year":"2017","journal-title":"Transl Res"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101173_bib62","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/jnnp-2019-320986","article-title":"Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: euro-MOTOR","volume":"91","author":"Peters","year":"2020","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.lanepe.2024.101173_bib63","article-title":"Could PLS represent a UMN-predominant ALS syndrome?","author":"Corcia","year":"2024","journal-title":"Rev Neurol"},{"issue":"sup1","key":"10.1016\/j.lanepe.2024.101173_bib64","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/21678421.2020.1837179","article-title":"Measuring disease progression in primary lateral sclerosis","volume":"21","author":"Gilmore","year":"2020","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"3","key":"10.1016\/j.lanepe.2024.101173_bib65","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/practneurol-2021-003256","article-title":"Diagnosing ALS: the Gold Coast criteria and the role of EMG","volume":"22","author":"Turner","year":"2022","journal-title":"Pract Neurol"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776224003429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776224003429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:20:25Z","timestamp":1778923225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776224003429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":65,"alternative-id":["S2666776224003429"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2024.101173","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between cardiometabolic diseases and the risk and progression of motor neuron diseases in Sweden: a population-based case\u2013control study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2024.101173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101173"}}